Oxford Properties kicks off €1.4b European life sciences strategy with Cambridge AstraZeneca HQ

Oxford Properties, the property arm of Canadian pension fund giant OMERS, has expanded its life sciences platform with its first European acquisition involving the AstraZeneca headquarters in Cambridge, UK.

Premium subscriber content – please log in to read more or take a free trial.

Events

Latest news

Best read stories